*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
|
1
|
NAME OF REPORTING PERSONS
Merlin Biomed Private Equity Advisors, LLC (IRS No. 13-4178606)
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
- 0 -
|
||
6
|
SHARED VOTING POWER
443,631
|
|||
7
|
SOLE DISPOSITIVE POWER
- 0 -
|
|||
8
|
SHARED DISPOSITIVE POWER
443,631
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
443,631
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.0%(1)
|
|||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
|
1
|
NAME OF REPORTING PERSONS
Merlin Nexus IV, L.P.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
- 0 -
|
||
6
|
SHARED VOTING POWER
443,631
|
|||
7
|
SOLE DISPOSITIVE POWER
- 0 -
|
|||
8
|
SHARED DISPOSITIVE POWER
443,631
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
443,631
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.0%(1)
|
|||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
1
|
NAME OF REPORTING PERSONS
Dominique Sémon
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
- 0 -
|
||
6
|
SHARED VOTING POWER
443,631
|
|||
7
|
SOLE DISPOSITIVE POWER
- 0 -
|
|||
8
|
SHARED DISPOSITIVE POWER
443,631
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
443,631
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.0%(1)
|
|||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
Item 1
|
(a).
|
Name of Issuer:
|
Item 1
|
(b).
|
Address of Issuer’s Principal Executive Offices:
|
Item 2
|
(a).
|
Name of Person Filing:
|
|
(i)
|
Merlin BioMed Private Equity Advisors, LLC
|
|
(ii)
|
Merlin Nexus IV, L.P.
|
|
(iii)
|
Dominique Sémon
|
Item 2
|
(b).
|
Address of Principal Business Office:
|
Item 2
|
(c).
|
Citizenship:
|
Item 2
|
(d).
|
Title of Class of Securities:
|
Item 2
|
(e).
|
CUSIP Number:
|
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
Item 4.
|
Ownership:
|
|
(a)
|
Amount beneficially owned: 443,631
|
|
(b)
|
Percent of class: 6.0%
|
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote: -0-
|
|
(ii)
|
Shared power to vote or to direct the vote: 443,631
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: -0-
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 443,631
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Item 9.
|
Notice of Dissolution of Group.
|
Item 10.
|
Certifications.
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
Merlin Biomed Private Equity Advisors, LLC | ||||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||
Title: | Managing Member | |||
Merlin Nexus IV, L.P. | ||||
By: | Merlin Nexus IV, LLC, General Partner | |||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||
Title: | Managing Member | |||
Dominique Sémon | ||||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||
CUSIP No. 89620X506
|
SCHEDULE 13G
|
CUSIP No. 89620X506
|
SCHEDULE 13G
|
Merlin Biomed Private Equity Advisors, LLC | ||||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||
Title: | Managing Member | |||
Merlin Nexus IV, L.P. | ||||
By: | Merlin Nexus IV, LLC, General Partner | |||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||
Title: | Managing Member | |||
Dominique Sémon | ||||
By: | /s/ Dominique Sémon | |||
Name: | Dominique Sémon | |||